365 related articles for article (PubMed ID: 33075664)
21. Design and Synthesis of Novel 4-Phenoxyquinolines Bearing 3-Hydrosulfonylacrylamido or 1H-Imidazole-4-carboxamido Scaffolds as c-Met Kinase Inhibitors.
Wang J; Xie L; Wang Y; Wang X; Xi S; Zeng T; Gong P; Zhai X
Arch Pharm (Weinheim); 2017 Feb; 350(2):. PubMed ID: 28133784
[TBL] [Abstract][Full Text] [Related]
22. Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study.
Wang R; Zhao X; Yu S; Chen Y; Cui H; Wu T; Hao C; Zhao D; Cheng M
Bioorg Chem; 2020 Sep; 102():104092. PubMed ID: 32707280
[TBL] [Abstract][Full Text] [Related]
23. Target identification, lead optimization and antitumor evaluation of some new 1,2,4-triazines as c-Met kinase inhibitors.
El-Wakil MH; Ashour HM; Saudi MN; Hassan AM; Labouta IM
Bioorg Chem; 2017 Aug; 73():154-169. PubMed ID: 28715754
[TBL] [Abstract][Full Text] [Related]
24. Uses of cyclohexane-1,3-dione for the synthesis of 1,2,4-triazine derivatives as anti-proliferative agents and tyrosine kinases inhibitors.
Megally Abdo NY; Milad Mohareb R; Halim PA
Bioorg Chem; 2020 Apr; 97():103667. PubMed ID: 32087416
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents.
Tang Q; Zhao Y; Du X; Chong L; Gong P; Guo C
Eur J Med Chem; 2013 Nov; 69():77-89. PubMed ID: 24012712
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and bioevaluation study of novel N-methylpicolinamide and thienopyrimidine derivatives as selectivity c-Met kinase inhibitors.
Wang L; Xu S; Chen X; Liu X; Duan Y; Kong D; Zhao D; Zheng P; Tang Q; Zhu W
Bioorg Med Chem; 2018 Jan; 26(1):245-256. PubMed ID: 29203143
[TBL] [Abstract][Full Text] [Related]
27. Design and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives bearing an imidazolone moiety as c-Met kinase inhibitors.
Liao W; Hu G; Guo Z; Sun D; Zhang L; Bu Y; Li Y; Liu Y; Gong P
Bioorg Med Chem; 2015 Aug; 23(15):4410-4422. PubMed ID: 26169763
[TBL] [Abstract][Full Text] [Related]
28. Discovery of novel 7-azaindole derivatives bearing dihydropyridazine moiety as c-Met kinase inhibitors.
Tang Q; Wang L; Duan Y; Wang W; Huang S; Zhi J; Jia S; Zhu W; Wang P; Luo R; Zheng P
Eur J Med Chem; 2017 Jun; 133():97-106. PubMed ID: 28384549
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of 4-(2-fluorophenoxy)-3,3'-bipyridine derivatives as potential c-met inhibitors.
Zhao S; Zhang Y; Zhou H; Xi S; Zou B; Bao G; Wang L; Wang J; Zeng T; Gong P; Zhai X
Eur J Med Chem; 2016 Sep; 120():37-50. PubMed ID: 27187857
[TBL] [Abstract][Full Text] [Related]
30. Novel 4-phenoxypyridine derivatives bearing imidazole-4-carboxamide and 1,2,4-triazole-3-carboxamide moieties: Design, synthesis and biological evaluation as potent antitumor agents.
Liu J; Liu F; Li Z; Li C; Wu S; Shen J; Wang H; Du S; Wei H; Hou Y; Ding S; Chen Y
Bioorg Chem; 2022 Mar; 120():105629. PubMed ID: 35078047
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives as selective c-Met inhibitors.
Wang X; Jiang N; Zhao S; Xi S; Wang J; Jing T; Zhang W; Guo M; Gong P; Zhai X
Bioorg Med Chem; 2017 Feb; 25(3):886-896. PubMed ID: 28011202
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of a series of pyridine and pyrimidine derivatives as type II c-Met inhibitors.
Zhao Y; Zhang J; Zhuang R; He R; Xi J; Pan X; Shao Y; Pan J; Sun J; Cai Z; Liu S; Huang W; Lv X
Bioorg Med Chem; 2017 Jun; 25(12):3195-3205. PubMed ID: 28412159
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 2-oxo-4-chloro-1,2-dihydroquinoline-3-carboxamide moiety.
Tang Q; Zhai X; Tu Y; Wang P; Wang L; Wu C; Wang W; Xie H; Gong P; Zheng P
Bioorg Med Chem Lett; 2016 Apr; 26(7):1794-8. PubMed ID: 26944614
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel 6,7-dimethoxy-4-anilinoquinolines as potent c-Met inhibitors.
Zhang QW; Ye ZD; Shen C; Tie HX; Wang L; Shi L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):124-133. PubMed ID: 30422010
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
[TBL] [Abstract][Full Text] [Related]
36. Transforming Type II to Type I c-Met kinase inhibitors via combined scaffold hopping and structure-guided synthesis of new series of 1,3,4-thiadiazolo[2,3-c]-1,2,4-triazin-4-one derivatives.
El-Wakil MH; Teleb M
Bioorg Chem; 2021 Nov; 116():105304. PubMed ID: 34534756
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel pyrrolo[2,3-b]pyridine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
Tang Q; Wang L; Tu Y; Zhu W; Luo R; Tu Q; Wang P; Wu C; Gong P; Zheng P
Bioorg Med Chem Lett; 2016 Apr; 26(7):1680-4. PubMed ID: 26923692
[TBL] [Abstract][Full Text] [Related]
38. Design, Synthesis, and Biological Evaluation of 4-Phenoxyquinoline Derivatives Containing Benzo[d]thiazole-2-yl Urea as c-Met Kinase Inhibitors.
Lei H; Hu G; Wang Y; Han P; Liu Z; Zhao Y; Gong P
Arch Pharm (Weinheim); 2016 Aug; 349(8):651-61. PubMed ID: 27283017
[TBL] [Abstract][Full Text] [Related]
39. Discovery of a novel 6,7-disubstituted-4-(2-fluorophenoxy)quinolines bearing 1,2,3-triazole-4-carboxamide moiety as potent c-Met kinase inhibitors.
Liu M; Hou Y; Yin W; Zhou S; Qian P; Guo Z; Xu L; Zhao Y
Eur J Med Chem; 2016 Aug; 119():96-108. PubMed ID: 27155466
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and pharmacological evaluation of 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents.
Zhou S; Ren J; Liu M; Ren L; Liu Y; Gong P
Bioorg Chem; 2014 Dec; 57():30-42. PubMed ID: 25173590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
